We are proud to announce our cooperation with BioPortUSA based in Syracuse, NY as from April 1st. This will give a new, pro-active access for Nordic based Medtech and Lifescience companies to the US market. Our combined service now range from financial services, business planning and strategy as well as regulatory, market entry and IP validations.to name some of the areas we jointly will cover.

From the CEO, Mark Lesselroth: “BioPortUSA provides management services uniquely tailored for foreign-based medtech and life sciences companies wishing to enter the US market. Our experience and knowledge of this highly regulated and complex healthcare industry enables our clients to accelerate the path to commercialization within a framework that maximizes cost-efficiencies – we therefore welcome CompanyCapital in Denmark as a new business partner”.

CEO Carsten Faerge of CompanyCapital: “This is a unique opportunity for Nordic companies looking to find a strong business partner that will cover most of the challenges Medtech and Lifescience companies face when considering entry or growth in the US market. CompanyCapital will cover capital, funding and business planning regionally and we team up with BioPortUSA early in the process in order to most efficiently assist clients looking at the USA as a potential market”.